Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cunningham

Showing results (21-30 of 621) with videos related to

Pageof 63
Sort By:
Current Oncology Reports|March 31, 2012
Toward the non-surgical management of locally advanced rectal cancerAlice Dewdney, David Cunningham
Lancet (London, England)|June 7, 2011
First-line treatment of advanced colorectal cancerMadeleine Hewish, David Cunningham
Clinical Colorectal Cancer|July 16, 2010
Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questionsSusana Banerjee, David Cunningham
Onkologie|March 24, 2005
What is the role of mitomycin C in advanced gastric cancer?Geoff Chong, David Cunningham
European Journal of Cancer (Oxford, England : 1990)|March 4, 2008
Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancerChristopher Jackson, David Cunningham
The New England Journal of Medicine|April 5, 2002
Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?Ian Chau, David Cunningham
Future Oncology (London, England)|December 5, 2014
Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerFrancesco Sclafani, David Cunningham
Gut|October 16, 2010
Optimal treatment of metastatic pancreatic cancerDavid Cunningham, Irene Chong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Relationship between colorectal cancer biomarkers and response to epidermal growth factor receptor monoclonal antibodiesEliza Hawkes, David Cunningham
Current Oncology Reports|April 26, 2005
Second-line therapy for advanced colorectal carcinomaNaureen Starling, David Cunningham
Pageof 63

Showing results (21-30 of 621) with videos related to

Sort By:
Pageof 63
Current Oncology Reports|March 31, 2012
Toward the non-surgical management of locally advanced rectal cancerAlice Dewdney, David Cunningham
Lancet (London, England)|June 7, 2011
First-line treatment of advanced colorectal cancerMadeleine Hewish, David Cunningham
Clinical Colorectal Cancer|July 16, 2010
Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questionsSusana Banerjee, David Cunningham
Onkologie|March 24, 2005
What is the role of mitomycin C in advanced gastric cancer?Geoff Chong, David Cunningham
European Journal of Cancer (Oxford, England : 1990)|March 4, 2008
Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancerChristopher Jackson, David Cunningham
The New England Journal of Medicine|April 5, 2002
Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?Ian Chau, David Cunningham
Future Oncology (London, England)|December 5, 2014
Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerFrancesco Sclafani, David Cunningham
Gut|October 16, 2010
Optimal treatment of metastatic pancreatic cancerDavid Cunningham, Irene Chong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Relationship between colorectal cancer biomarkers and response to epidermal growth factor receptor monoclonal antibodiesEliza Hawkes, David Cunningham
Current Oncology Reports|April 26, 2005
Second-line therapy for advanced colorectal carcinomaNaureen Starling, David Cunningham
Pageof 63